Adeshwar Meditex Limited (BOM:543309)

Market Cap	230.90M -41.7%
Revenue (ttm)	561.04M -33.0%
Net Income	12.65M -38.8%
EPS	0.88 -38.5%
Shares Out	14.43M
PE Ratio	18.18
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,000
Open	16.00
Previous Close	15.55
Day's Range	16.00 - 16.00
52-Week Range	13.00 - 21.80
Beta	0.80
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 12, 2026

About Adeshwar Meditex

Adeshwar Meditex Limited manufactures and exports sterile surgical wound dressing products and medical disposables in India and internationally. It offers sterile wound dressings under PETRONET, PARAHEAL, BACTIGAUZE PLUS, NITROHEAL, PIVIDINE POVITULLE, POVIZOLE, FRAMITULLE, FUSITULLE, CALGINATE-AG SILVINET, HYDRASOOTHE, POLYBANE, and POLYBANE-N brands; combine dressings, including eye pads under the COMBIDRESS and COMBIPAD brands; and gauze dressing and cotton products, such as cotton stockinette, kneecaps, cast paddings under the ORTHOWRAP bra...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 1951
• Employees: 26
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 543309

Financial Performance

In fiscal year 2026, Adeshwar Meditex's revenue was 561.04 million, a decrease of -32.98% compared to the previous year's 837.13 million. Earnings were 12.65 million, a decrease of -38.77%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jul 13, 2026

Data Sources Report a data error